The Department of Health and Social Care has issued a medicines supply notice (MSN) confirming that Novo Nordisk’s Tresiba® U100 FlexTouch® disposable insulin pen is expected to be out of stock within the UK from the beginning of August. This does not affect presentations of Tresiba in other devices or doses.
This MSN follows the notice earlier this week regarding a temporary shortage of the GlucaGen® (glucagon) HypoKit®.
Summary points from Medicines Supply Notification MSN/2023/053
- Tresiba® FlexTouch® (Insulin degludec) 100units/ml pens will be out of stock from August 2023 until January 2024.
- Tresiba Penfill® (Insulin degludec) 100units/ml solution for injection 3ml cartridges remain available and can support increased demand.
A copy of this medicine supply notification, including further information for pharmacy teams, has been sent to all pharmacy NHS email addresses.
The online Medicines Supply Tool provides up to date information about medicine supply issues. The contents of these MSNs can now be viewed on the tool, which also details any changes to resupply dates and updates to the entries. To access the tool you will need an NHS email address. Once set up and logged in, you will be able to access it online.
